SOW
CCCC icon

State of Wyoming’s C4 Therapeutics CCCC Stock Holding History

State of Wyoming’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.2K Buy
+16,093
New +$55K 0.01% 1511
2025
Q4 		– Sell
-82,509
Closed -$183K – 1840
2025
Q3 		$183K Buy
+82,509
New +$198K 0.02% 1011
2023
Q3 		– Sell
-34,494
Closed -$94.9K – 1649
2023
Q2 		$94.9K Buy
+34,494
New +$111K 0.03% 865

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State of Wyoming's CCCC Position: Q2 2026 in Review

State of Wyoming opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 16,093 shares worth $75.2K. The stake represents 0.01% of the portfolio and ranks #1511 among its holdings. This is a return to the name: State of Wyoming previously reported a position in CCCC as recently as Q3 2025.

State of Wyoming first reported a position in CCCC in Q2 2023 and has held it in 3 quarters since. The position peaked at $183K in Q3 2025. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • State of Wyoming held 16,093 shares of C4 Therapeutics worth $75.2K as of Q2 2026.
  • C4 Therapeutics was a new State of Wyoming position in Q2 2026.
  • C4 Therapeutics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1511 holding.
  • State of Wyoming first reported a position in C4 Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • State of Wyoming's C4 Therapeutics position peaked at $183K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.